ArticleOncology letters2018

Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.

Wentao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.